RhumbLine Advisers’s Tonix Pharmaceuticals TNXP Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $406K | Sell |
11,298
-2,372
| -17% | -$85.3K | ﹤0.01% | 2812 |
|
|
2025
Q1 | $244K | Buy |
+13,670
| New | +$244K | ﹤0.01% | 3005 |
|
|
2022
Q2 | – | Sell |
-1
| Closed | -$86K | – | 3234 |
|
|
2022
Q1 | $86K | Hold |
1
| – | – | ﹤0.01% | 2915 |
|
|
2021
Q4 | $129K | Hold |
1
| – | – | ﹤0.01% | 2908 |
|
|
2021
Q3 | $202K | Hold |
1
| – | – | ﹤0.01% | 2913 |
|
|
2021
Q2 | $358K | Buy |
+1
| New | +$358K | ﹤0.01% | 2720 |
|